Ads
related to: gastroparesis medicine that give relief to asthma- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily Asthma Treatment.
- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily Asthma Inhaler.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy Asthma Option.
- Formulary Coverage
See If Your Patients Are Covered
With This Daily Asthma Treatment.
- Important Safety Info
Read About Safety & Side Effects
For An Asthma Triple Therapy.
- Efficacy Information
Evaluate The Efficacy Results
For This Once-Daily Asthma Inhaler.
- Adverse Reactions
Search results
Results From The WOW.Com Content Network
The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related hospital visits. Anti-asthmatic agents as rescue medications for acute asthma attacks include short-acting β 2-adrenergic receptor agonists (SABA), short-acting muscarinic antagonists (SAMA), systemic glucocorticoids, and magnesium sulfate.
These drugs are used for the treatment of asthma. They may be useful either in the treatment or prevention of asthma attacks. Subcategories.
They are primarily used to treat asthma and other pulmonary disorders. Bronchodilators are considered an important treatment regime for chronic obstructive pulmonary disease (COPD) and are usually used in combination with short acting medications and long acting medications in a combined inhaler. [1] [2]
Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2] It contains budesonide , a steroid ; and formoterol , a long-acting β 2 -agonist (LABA). [ 2 ]
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
The β 2-selective agonists were developed in the 20th century and are a very valuable class of drugs. In 1901 Jōkichi Takamine isolated the hormone adrenalin, also known as epinephrine. [1] In 1890 adrenalin was first given to asthma patients orally. It had little or no effect because it is metabolized in the digestive tract and is deactivated.